rs774455553

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_021098.3(CACNA1H):​c.4448G>A​(p.Arg1483His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000354 in 1,610,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000035 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 2.91
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26861805).
BP6
Variant 16-1211578-G-A is Benign according to our data. Variant chr16-1211578-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 529564.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.4448G>A p.Arg1483His missense_variant Exon 23 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.4448G>A p.Arg1483His missense_variant Exon 23 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000565831.6 linkc.4448G>A p.Arg1483His missense_variant Exon 22 of 33 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkc.4409G>A p.Arg1470His missense_variant Exon 23 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000569107.5 linkc.671G>A p.Arg224His missense_variant Exon 6 of 17 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000564231.5 linkc.671G>A p.Arg224His missense_variant Exon 6 of 18 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000562079.5 linkc.671G>A p.Arg224His missense_variant Exon 6 of 17 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000639478.1 linkn.4448G>A non_coding_transcript_exon_variant Exon 23 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2361G>A non_coding_transcript_exon_variant Exon 23 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000640028.1 linkn.*2361G>A 3_prime_UTR_variant Exon 23 of 35 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000663
AC:
16
AN:
241224
Hom.:
0
AF XY:
0.0000683
AC XY:
9
AN XY:
131862
show subpopulations
Gnomad AFR exome
AF:
0.0000694
Gnomad AMR exome
AF:
0.000177
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000568
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000645
Gnomad OTH exome
AF:
0.000170
GnomAD4 exome
AF:
0.0000350
AC:
51
AN:
1457958
Hom.:
0
Cov.:
35
AF XY:
0.0000331
AC XY:
24
AN XY:
725142
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000180
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000505
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000324
Gnomad4 OTH exome
AF:
0.0000830
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152240
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000675
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000249
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Dec 27, 2023
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

CACNA1H-related disorder Uncertain:1
Mar 06, 2024
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

The CACNA1H c.4448G>A variant is predicted to result in the amino acid substitution p.Arg1483His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.017% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.0056
T
BayesDel_noAF
Uncertain
0.020
CADD
Pathogenic
27
DANN
Benign
0.90
DEOGEN2
Benign
0.37
T;.;.;.
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.028
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.85
D;D;D;.
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.27
T;T;T;T
MetaSVM
Uncertain
0.55
D
MutationAssessor
Benign
0.45
N;.;N;N
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
2.4
N;.;N;N
REVEL
Uncertain
0.52
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
1.0
T;.;T;T
Polyphen
0.65
P;.;B;B
Vest4
0.66
MutPred
0.63
Loss of MoRF binding (P = 0.0343);.;Loss of MoRF binding (P = 0.0343);Loss of MoRF binding (P = 0.0343);
MVP
0.91
ClinPred
0.12
T
GERP RS
4.0
Varity_R
0.22
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs774455553; hg19: chr16-1261578; COSMIC: COSV100673301; COSMIC: COSV100673301; API